Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.42
-9.8%
$0.49
$0.19
$1.01
$10.34M1.2135,648 shs42,017 shs
Lifeward Ltd. stock logo
LFWD
Lifeward
$1.03
-3.7%
$1.30
$1.00
$4.77
$11.34M0.16698,956 shs146,552 shs
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$0.40
-3.6%
$0.37
$0.25
$1.47
$13.07M0.85691,453 shs88,931 shs
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
$2.75
$3.32
$2.49
$5.75
$4.41M-1.18140 shsN/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biotricity, Inc. stock logo
BTCY
Biotricity
0.00%-20.19%-20.19%-12.43%-55.74%
Lifeward Ltd. stock logo
LFWD
Lifeward
0.00%-6.36%-18.25%-40.12%-75.53%
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
0.00%+15.94%+2.33%+15.53%-53.25%
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
0.00%0.00%-22.10%-31.25%-47.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/AN/AN/AN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
2.0961 of 5 stars
3.53.00.00.00.80.01.3
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biotricity, Inc. stock logo
BTCY
Biotricity
2.00
HoldN/AN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
3.00
Buy$9.00773.79% Upside
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
0.00
N/AN/AN/A
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biotricity, Inc. stock logo
BTCY
Biotricity
$12.06M0.86N/AN/A($1.30) per share-0.32
Lifeward Ltd. stock logo
LFWD
Lifeward
$25.66M0.44N/AN/A$2.14 per share0.48
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$96.90M0.13$0.44 per share0.90$6.34 per share0.06
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
N/AN/AN/AN/A($2.78) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biotricity, Inc. stock logo
BTCY
Biotricity
-$14.09M-$1.08N/AN/A-80.42%N/A-188.47%6/25/2025 (Estimated)
Lifeward Ltd. stock logo
LFWD
Lifeward
-$28.94M-$3.04N/AN/AN/A-108.21%-101.96%-70.49%8/13/2025 (Estimated)
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$10.84MN/A0.00N/AN/AN/AN/AN/A
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
-$3.34M-$4.57N/AN/AN/AN/A-2,014.27%N/A

Latest SIGY, MHUA, BTCY, and LFWD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/25/2025N/A
Biotricity, Inc. stock logo
BTCY
Biotricity
-$0.10N/AN/AN/A$3.60 millionN/A
5/20/2025Q1 2025
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
N/A-$0.42N/A-$0.42N/AN/A
5/15/2025Q1 2025
Lifeward Ltd. stock logo
LFWD
Lifeward
-$0.33-$0.46-$0.13-$0.46$5.84 million$5.03 million
4/15/2025Q4 2024
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
N/A-$2.51N/A-$2.51N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
N/AN/AN/AN/AN/A
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
N/AN/AN/AN/AN/A
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biotricity, Inc. stock logo
BTCY
Biotricity
N/A
0.23
0.10
Lifeward Ltd. stock logo
LFWD
Lifeward
N/A
2.18
1.43
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
N/A
5.26
5.21
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
N/A
0.01
0.01

Institutional Ownership

CompanyInstitutional Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
3.89%
Lifeward Ltd. stock logo
LFWD
Lifeward
26.76%
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
1.17%
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
10.01%

Insider Ownership

CompanyInsider Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
10.10%
Lifeward Ltd. stock logo
LFWD
Lifeward
2.50%
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
66.56%
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
78.46%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biotricity, Inc. stock logo
BTCY
Biotricity
4024.91 million22.08 millionOptionable
Lifeward Ltd. stock logo
LFWD
Lifeward
6011.01 million10.73 millionOptionable
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
62031.90 million10.67 millionNot Optionable
Sigyn Therapeutics, Inc. stock logo
SIGY
Sigyn Therapeutics
51.61 million346,000Not Optionable

Recent News About These Companies

Sigyn Therapeutics Delays Yearly Report Filing
Sigyn Therapeutics, Inc. (SIGY)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biotricity stock logo

Biotricity NASDAQ:BTCY

$0.42 -0.05 (-9.78%)
As of 06/20/2025 03:59 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Lifeward stock logo

Lifeward NASDAQ:LFWD

$1.03 -0.04 (-3.74%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$1.07 +0.04 (+4.27%)
As of 06/20/2025 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Meihua International Medical Technologies stock logo

Meihua International Medical Technologies NASDAQ:MHUA

$0.40 -0.01 (-3.64%)
Closing price 06/20/2025 03:09 PM Eastern
Extended Trading
$0.38 -0.02 (-5.06%)
As of 06/20/2025 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.

Sigyn Therapeutics stock logo

Sigyn Therapeutics OTCMKTS:SIGY

$2.75 0.00 (0.00%)
As of 06/20/2025

Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.